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Purpose: Peritoneal dialysis (PD) is a successful renal replacement therapy; however, long-term 
PD leads to structural and functional peritoneal damage. Therefore, the monitoring and estima-
tion of peritoneal function are important in PD patients. Oxidative stress has been implicated as 
one possible mechanism of peritoneal membrane damage. The aim of this study was to evaluate 
the association between an oxidative stress marker, 8-hydroxydeoxyguanosine (8-OHdG), and 
peritoneal damage in PD patients.
Methods: The authors evaluated 8-OHdG in drained dialysate by enzyme immunoassay to 
investigate the association between 8-OHdG and solute transport rate estimated by peritoneal 
equilibration test and matrix metalloproteinase-2 (MMP-2) level in 45 samples from 28 PD 
patients.
Results: The 8-OHdG level was significantly correlated with dialysate:plasma creatine ratio 
(r = 0.463, P , 0.05) and significantly inversely correlated with D/D0 glucose (where D is the 
glucose level of peritoneal effluents obtained 4 hours after the injection and D0 is the glucose 
level obtained immediately after the injection) (r = −0.474, P , 0.05). The 8-OHdG level was 
also significantly correlated with MMP-2 level (r = 0.551, P , 0.05), but it was not correlated 
with the age of subjects, the duration of PD, or blood pressure.
Conclusion: The level of 8-OHdG in drained dialysate may be a useful novel marker of peri-
toneal damage in PD.
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Introduction
Peritoneal dialysis (PD) is a successful renal replacement therapy for end-stage renal 
disease patients.1,2 It is suitable as the first method of renal replacement therapy; 
however, long-term PD leads to peritoneal damage.3,4 This peritoneal damage has 
been found to be characterized by progressive increase in the thickness of peritoneal 
membrane, predominantly in the submesothelial collagenous area, declining ultrafiltra-
tion loss, and an increased solute transport rate.4–6 This damage makes it difficult to 
continue PD therapy and may occasionally cause encapsulating peritoneal sclerosis 
(EPS), which is a serious, life-threatening complication in PD patients.7,8 Therefore, 
both monitoring and estimation of peritoneal function are important in PD patients. 
As an estimator of peritoneal damage, the solute transport rate is usually measured 
by the peritoneal equilibration test (PET);9,10 however, PET is an invasive and time-
consuming method because it requires blood sampling and it takes half a day for 
patients. Therefore, it is important to estimate peritoneal damage using a conventional 
and noninvasive method.
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The mechanisms involved in structural and functional 
peritoneal changes remain unclear. Oxidative stress has 
been implicated as one possible mechanism of peritoneal 
membrane damage.11 PD fluid containing high concentra-
tions of glucose has been reported to increase cellular 
reactive oxygen species (ROS).12 In addition, recent stud-
ies have reported the beneficial effects of antioxidants on 
preservation of the structural and functional integrity of the 
peritoneal membrane.13,14 From these lines of evidence, the 
authors hypothesized that an oxidative stress marker may 
be a useful marker of peritoneal damage in PD patients. 
To test this hypothesis, the authors measured an oxidative 
stress marker, 8-hydroxydeoxyguanosine (8-OHdG), in 
drained dialysate and investigated the association between 
the 8-OHdG level and the solute transport rate estimated 
by PET and matrix metalloproteinase-2 (MMP-2) level, 
which was reported to be a marker of peritoneal damage 
in PD patients.15,16
Material and methods
This study was performed in accordance with the Declaration 
of Helsinki and was approved by the ethics committee of Jichi 
Medical University. Written informed consent was obtained 
from all patients.
Subjects
A total of 45 drained dialysate samples from 28 PD patients 
(18 males and 10 females, mean age 56.3 ± 13.1 years, 
ranging from 25 to 78 years) were investigated. The 
patients’ initial nephropathies were chronic glomerulo-
nephritis (eleven patients), diabetic nephropathy (eight 
patients), lupus nephritis (one patient), drug nephropa-
thy (one patient), chronic renal sclerosis (two patients), 
gout kidney (one patient), and unknown etiology (four 
patients). Nine patients had a history of peritonitis due 
to infection with a pathogenic organism and were treated 
with antibiotics.
PET
Peritoneal solute transport was assessed with the PET.10 
Drainage of intra-abdominal fluid was followed by an 
intraperitoneal injection of 2 L of PD fluid containing 
2.27%–2.5% glucose. The creatinine (Cr) level of peritoneal 
effluents obtained 4 hours after the injection (D) was divided 
by that of plasma (P) to obtain the D/P Cr ratio. The glucose 
level of peritoneal effluents obtained 4 hours after the 
injection (D) was divided by that obtained immediately after 
the injection (D0) to obtain the D/D0 glucose ratio.
Laboratory methods
The concentrations of 8-OHdGH and MMP-2 in the drained 
dialysate obtained from the PET were measured by enzyme-
linked immunosorbent assay (ELISA).
The 8-OHdG ELISA
The Highly Sensitive 8-OHdG Check ELISA kit (Japan 
Institute for the Control of Aging [JaICA], Nikken SEIL Co, 
Shizuoka, Japan) was used according to the manufacturer’s 
protocol. Briefly, 8-OHdG monoclonal antibody and 50 µL of 
peritoneal effluents were added to the microtiter plate, which 
had been precoated with 8-OHdG. Following this, 50 µL of 
reconstituted primary antibody to 8-OHdG was added per 
well and incubated at 4°C overnight. After three washes, the 
reconstituted secondary antibody was added and incubated 
at room temperature for 1 hour. After three more washes, 
substrate was added to each well and incubated at room tem-
perature for 15 minutes. The reaction-terminating solution 
was then added and the absorbance was read at 450 nm.
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Table 1 Patients’ baseline characteristics (N = 28)
Parameter Statistics
Age (years) 56.3 ± 13.1
Gender
  Male 18
  Female 10
BMI (kg/m2) 23.4 ± 4.3
Duration of PD (years) 1.9 ± 2.1
Peritonitis history (number of times)
 0 19
 1 5
 2 2
 3 1
 4 1
Initial nephropathy
  Chronic glomerulonephritis 11
  Diabetic nephropathy 8
  Lupus nephritis 1
  Drug nephropathy 1
  Renal sclerosis 2
  Gout kidney 1
  Unknown 4
SBP (mmHg) 146.5 ± 27.6
DBP (mmHg) 83.3 ± 12.8
Hemoglobin (g/dL) 9.8 ± 1.3
Albumin (g/dL) 3.2 ± 0.3
Note: Age, BMI, duration of PD, SBP, DBP, hemoglobin, and albumin data are 
expressed as the mean plus or minus the standard deviation.
Abbreviations:  BMI,  body  mass  index;  DBP,  diastolic  blood  pressure; 
PD, peritoneal dialysis; SBP, systolic blood pressure.International Journal of Nephrology and Renovascular Disease 2012:5
The MMP-2 ELISA
MMP-2 ELISA was performed using the Biotrak MMP-2 
ELISA kit (GE Healthcare, Piscataway, NJ) according to the 
manufacturer’s protocol. Briefly, standards and samples were 
incubated in microtiter wells precoated with an anti-MMP-2 
antibody. Bound MMP-2 was detected using a peroxidase-
labeled Fab’ antibody to MMP-2 and any excess was removed 
by washing and aspiration. The amount of peroxidase bound 
to each well was determined by addition of a 3,3′,5,5′-tetram-
ethylbenzidine substrate. The reaction was stopped and the 
resultant color was read at 450 nm.
Statistical analysis
All data are expressed as the mean plus or minus the standard 
deviation. The means of indicated groups were compared 
using Student’s t-test. Relationships between continuous 
variables were analyzed using Pearson correlation tests or 
linear regression analysis. Differences with a P-value less 
than 0.05 were considered statistically significant.
Results
Patient characteristics are presented in Table 1. Their dura-
tion of PD was 1.9 ± 2.1 years. Their systolic blood pressure 
(SBP) was 146.5 ± 27.6 mmHg and diastolic blood pressure 
(DBP) was 83.3 ± 12.8 mmHg. The patients’ hemoglobin 
and albumin levels were low: hemoglobin was 9.8 ± 1.3 g/dL 
and albumin was 3.2 ± 0.3 g/dL. The 8-OHdG levels in 
drained dialysate were not significantly different by sex, 
initial nephropathy (diabetic or nondiabetic), or past history 
of peritonitis (Figure 1).
Correlation between the 8-OHdG 
concentration and the peritoneal solute 
transport rate and MMP-2 level
The 8-OHdG level in the drained dialysate was significantly 
correlated with D/P Cr (r = 0.463, P , 0.05) and signifi-
cantly inversely correlated with D/D0 glucose (r = −0.474, 
P , 0.05) in PD patients (Figure 2A). The 8-OHdG level in 
the drained dialysate was also   significantly correlated with 
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Figure 1 The level of 8-hydroxydeoxyguanosine (8-OHdG) in drained dialysate in peritoneal dialysis (PD) patients. Comparison of 8-OHdG levels in drained dialysate 
between (A) males and females, (B) those who had diabetic nephropathy (DMN) and those who did not (non-DMN), and (C) those who had a past history of peritonitis 
and those who did not.
Note: Columns represent the mean plus or minus standard error.
Abbreviation: NS, no statistical significance.
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Figure 2 Correlation between the 8-hydroxydeoxyguanosine (8-OHdG) level in drained dialysate and the peritoneal solute transport rate, determined by peritoneal 
equilibration test and matrix metalloproteinase-2 (MMP-2) level in drained dialysate: 8-OHdG level and (A) dialysate:plasma creatine ratio (D/P Cr), D/D0 glucose (where D is 
the glucose level of peritoneal effluents obtained 4 hours after the injection and D0 is the glucose level obtained immediately after the injection), and MMP-2 level in peritoneal 
dialysis (PD) patients and (B) D/P Cr, D/D0 glucose, and MMP-2 level in those PD patients who had a past history of peritonitis and in those PD patients who did not.
MMP-2 level in the drained dialysate (r = 0.551, P , 0.05) 
(Figure 2A). In the subanalysis based on past history of peri-
tonitis, 8-OHdG level in the drained dialysate correlated with 
D/P Cr and inversely correlated with D/D0 glucose in both 
the PD patients who had a past history of peritonitis (D/P Cr: 
r = 0.474, P , 0.05; D/D0 glucose: r = −0.646, P , 0.05) and 
the PD patients who did not have a past history of peritonitis 
(D/P Cr: r = 0.420, P , 0.05; D/D0 glucose: r = −0.376, 
P , 0.05) (Figure 2B). On the other hand, 8-OHdG level 
in the drained dialysate was significantly correlated with 
MMP-2 level in drained dialysate in the PD patients who had 
a past history of peritonitis (r = 0.730, P , 0.05); however, 
it was not correlated with MMP-2 level in drained dialysate 
in those PD patients who did not have past history of peri-
tonitis (Figure 2B).
Characteristics of 8-OHdG concentration 
in drained dialysate in PD patients
The 8-OHdG level in drained dialysate was not corre-
lated with the age of subjects or the duration of PD in PD 
patients (Figure 3A). The 8-OHdG in drained dialysate was 
also not correlated with the SBP or DBP in PD patients 
(Figure 3B).
Discussion
The results of this study show that 8-OHdG level in drained 
dialysate was significantly correlated with the solute transport 
rate, which was determined by PET. In addition, 8-OHdG 
level in drained dialysate was not correlated with age of 
PD patients, their duration of PD, or their blood pressure 
(BP). These results suggested that 8-OHdG level in drained 
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Figure 3 Correlation between the 8-hydroxydeoxyguanosine (8-OHdG) level in drained dialysate and the peritoneal dialysis (PD) duration and age of subject: 8-OHdG level 
and (A) PD duration and age of subject and (B) systolic blood pressure (SBP) and diastolic blood pressure (DBP).
dialysate reflects peritoneal damage and could be a novel 
marker of peritoneal damage. This is the first study to dem-
onstrate a significant correlation between 8-OHdG level in 
drained dialysate and peritoneal damage in PD patients. The 
oxidative stress marker 8-OHdG is one of the most abundant 
oxidative products of DNA. Several studies have reported 
that 8-OHdG is a useful marker for assessment of oxidative 
DNA damage by ROS, including that in end-stage renal 
disease patients.17,18
The mechanisms involved in peritoneal structural and 
functional changes remain unclear; however, several stud-
ies have reported that ROS contributed to multiple factors 
inducing peritoneal damage.13,14,19 Noh et al13 reported that 
increase of omental transforming growth factor beta-1 
(TGF-β1), vascular endothelial growth factor (VEGF), and 
type I collagen by conventional PD solution was blocked by 
an antioxidant, N-acetylcysteine, in an animal model. Kihm 
et al14 also reported that increase of TGF-β1, alpha smooth 
muscle actin, VEGF, and vessels per area in peritoneum by 
PD fluid was attenuated by an antioxidant, benfotiamine, in 
an animal model. They also reported interleukin (IL)-6- and 
CD3-positive cells per area in peritoneum were increased 
by PD fluid and that this increased IL-6 was blocked by 
benfotiamine.14 Gotloib et al19 reported that oxidative stress 
induced peritoneal fibrosis and sclerosis characterized by 
peritoneal adhesions, wrapping of intestinal loops, and the 
presence of a layer of fibrous tissue in animal PD model. 
These results suggest that ROS contribute to inflammation, 
fibrosis, revascularization, and sclerosis in PD.
Cancer antigen 125 (CA125) level can be considered 
as a marker for mesothelial cell mass and is often used as 
a marker of peritoneal injury.20–22 Although the downward 
trend with time of CA125 level in effluent suggested meso-
thelial cell mass, a single low value is difficult to interpret. 
MMP-2 level in drained dialysate has been reported to be 
associated with solute transport rate estimated with PET.16 
Furthermore, MMP-2 level in effluent has been reported 
to be markedly increased in patients with peritoneal injury 
including EPS.15
In this study of PD patients, 8-OHdG levels in drained 
dialysate were similar between those who had a past history 
of peritonitis and those who did not. In addition, these   levels 
were significantly correlated with D/P Cr and inversely 
correlated with D/D0 glucose, regardless of past history of 
peritonitis. On the other hand, 8-OHdG level in the drained 
dialysate was significantly correlated with MMP-2 level in 
drained dialysate in the PD patients who had a past history 
of peritonitis; however, it was not correlated with MMP-2 
level in drained dialysate in those who did not have a past 
history of peritonitis. These results suggest that past history 
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of peritonitis may contribute to peritoneal injury by associa-
tion with oxidative stress, and that 8-OHdG level in drained 
dialysate may be more strongly correlated with peritoneal 
injury in PD patients who have a past history of peritonitis 
than in PD patients who do not, beyond patients’ PD dura-
tion, age, and BP. These results also suggest that inhibition of 
oxidative stress in the peritoneum may be a good therapeutic 
option to prolong PD duration, especially in PD patients with 
a past history of peritonitis.
A limitation of this study was that the plasma 8-OHdG level 
of each sample was not measured to investigate which of local 
production of 8-OHdG in the peritoneum or increased leakage 
of plasma 8-OHdG into the dialysate was associated with peri-
toneal injury in PD patients. Further large and long-term studies 
will be needed to elucidate the production and regulation of 
8-OHdG and the association between 8-OHdG levels in drained 
dialysate and the development of peritoneal injury including 
EPS in PD. As it stands, 8-OHdG levels in drained dialysate 
could be used in combination with PET, MMP-2, and CA125 
level in drained dialysate to evaluate peritoneal injury.
Conclusion
In conclusion, the results of the present study suggest that 
8-OHdG level in drained dialysate may be a useful novel 
marker of peritoneal damage in PD.
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